Decoy Therapeutics Inc. ( DCOY) - Key Metrics
DCOY Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$4.46 | -$4.99 | -$5.07 |
| 2026Q1 | $0 | -$4.18 | -$5.43 | -$5.43 |
| 2025Q4 | $0 | -$18.64 | -$2.36 | -$2.36 |
| 2025Q3 | $0 | -$1.81 | -$3.42 | -$3.42 |
| 2025Q2 | $0 | -$6.77 | -$6.09 | -$6.09 |
DCOY Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.40 |
| 2026Q1 | 0% | -0.39 |
| 2025Q4 | 0% | -0.10 |
| 2025Q3 | 0% | -6.07 |
| 2025Q2 | 0% | -5.96 |
DCOY
Price: $3.72
52 week price:
Earnings Per Share: -24.24 USD
P/E Ratio: -0.03
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 2.2 million